Sr.Rayala.Hypo

When is the next results date for Sr.Rayala.Hypo?

No Upcoming Board Meetings

What does Sr.Rayala.Hypo do?

Sree Rayalaseema Hi-Strength Hypo Ltd is a small-cap company specializing in the production of Calcium Hypochlorite, Stable Bleaching Powder, and Sulphuric Acid. As of March 2025, it reported net sales of 160 Cr and a net profit of 22 Cr.

Overview:<BR>Sree Rayalaseema Hi-Strength Hypo Ltd is a leading producer of Calcium Hypochlorite, Stable Bleaching Powder, Sulphuric Acid, and other chemicals in the commodity chemicals industry, categorized as a small-cap company.<BR><BR>History:<BR>Incorporated in March 2005, Sree Rayalaseema Hi-Strength Hypo Ltd is recognized as the only Indian manufacturer of Calcium Hypochlorite and one of the few globally. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 160 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 22 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 1,095 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 13.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.44% <BR>Debt-Equity: -0.39 <BR>Return on Equity: 9.78% <BR>Price to Book: 1.22 <BR><BR>Contact Details:<BR>Address: Gondiparla, Kurnool Andhra Pradesh : 518004 <BR>Tel: 91-40-23313842 <BR>Fax: 91-40-23313875 <BR>Website: http://www.srhhl.com

Has Sr.Rayala.Hypo declared dividend?

Sree Rayalaseema Hi-Strength Hypo Ltd has declared a 30% dividend, amounting to 3 per share, with an ex-date of September 12, 2024. The dividend yield is 0.44%, and while the company has shown strong long-term returns, it experienced a -9.3% total return over the last 6 months.

Sree Rayalaseema Hi-Strength Hypo Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 12 Sep 24<BR><BR>Dividend Yield: 0.44%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -9.3%, the dividend return was 0%, resulting in a total return of -9.3%.<BR><BR>Over the past year, the price return was 26.45%, the dividend return was 0.54%, leading to a total return of 26.99%.<BR><BR>In the 2-year period, the price return was 4.28%, the dividend return was 1.11%, culminating in a total return of 5.39%.<BR><BR>For the 3-year period, the price return was 41.76%, the dividend return was 2.63%, which resulted in a total return of 44.39%.<BR><BR>In the last 4 years, the price return was 116.37%, the dividend return was 3.89%, yielding a total return of 120.26%.<BR><BR>Over the past 5 years, the price return was 516.93%, the dividend return was 12.61%, resulting in a total return of 529.54%.<BR><BR>Overall, while the company has declared a dividend, the recent total returns show mixed performance, with significant gains over longer periods but a negative return in the last 6 months. The dividend yield remains relatively low at 0.44%.

Who are the peers of the Sr.Rayala.Hypo?

Peers of Sr.Rayala.Hypo include Tata Chemicals, Chemplast Sanmar, GHCL, and others, with varying management risks and capital structures. POCL Enterprises has the highest 1-year return at 236.24%, while Sr.Rayala.Hypo's return is 12.85%.

Peers: The peers of Sr.Rayala.Hypo are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Tuticorin Alkali, Transpek Inds., Sadhana Nitro, and POCL Enterprises.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar, and the rest have Average or Below Average management risk. Below Average growth is noted for Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Sadhana Nitro, and the rest, while Average growth is seen at Tuticorin Alkali and Fischer Medical. Excellent capital structure is attributed to Sr.Rayala.Hypo, while Good capital structure is found at GHCL, Tuticorin Alkali, and Transpek Inds., and the rest have Average or Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is POCL Enterprises at 236.24%, while the lowest is Sadhana Nitro at -53.28%. Sr.Rayala.Hypo's 1-year return of 12.85% is significantly lower than that of POCL Enterprises but higher than Sadhana Nitro. Additionally, the six-month return is negative for Tata Chemicals, Chemplast Sanmar, Sr.Rayala.Hypo, Tuticorin Alkali, Sadhana Nitro, and Primo Chemicals.

Who are in the management team of Sr.Rayala.Hypo?

As of March 2022, the management team of Sr.Rayala.Hypo includes TUMBALAM GOOTY BHARATH (Chairman & Managing Director), V Surekha (Company Secretary), and several directors, with Bharath receiving a remuneration of 7.14 crore INR. The other members do not have reported remuneration.

As of March 2022, the management team of Sr.Rayala.Hypo includes the following members:<BR><BR>1. TUMBALAM GOOTY BHARATH - Chairman & Managing Director<BR>2. V Surekha - Company Secretary & Compliance Officer<BR>3. Krishna Moorthy Chandraiah Naik - Director<BR>4. P. Ramachandra Gowd - Independent Director<BR>5. A. Kailashnath - Independent Director<BR>6. H Gurunath Reddy - Director<BR>7. R Triveni - Independent Director<BR><BR>The Chairman & Managing Director, TUMBALAM GOOTY BHARATH, receives a remuneration of 7.14 crore INR, while the other members listed do not have any reported remuneration.

Who are the top shareholders of the Sr.Rayala.Hypo?

The top shareholders of Sr.Rayala.Hypo include Gowri Gopal Hospitals Private Limited with 21.8%, and individual investors who own 25.85%. There are minimal holdings from mutual funds and foreign institutional investors, with no pledged promoter holdings or significant public shareholders.

The top shareholders of Sr.Rayala.Hypo are primarily the promoters, with Gowri Gopal Hospitals Private Limited holding the largest stake at 21.8%. Additionally, individual investors collectively own 25.85% of the company. There are also some holdings by mutual funds and foreign institutional investors, but these represent a very small percentage of the overall ownership. Notably, there are no pledged promoter holdings or significant public shareholders.

How big is Sr.Rayala.Hypo?

As of 24th July, Sree Rayalaseema Hi-Strength Hypo Ltd has a market capitalization of 1,151.00 Cr, with recent Net Sales of 637.82 Cr and a Net Profit of 87.47 Cr.

As of 24th July, Sree Rayalaseema Hi-Strength Hypo Ltd has a market capitalization of 1,151.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 637.82 Cr and a Net Profit of 87.47 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 800.61 Cr and Total Assets valued at 914.00 Cr.

Is Sr.Rayala.Hypo technically bullish or bearish?

As of October 1, 2025, the technical trend has shifted to a moderately strong bearish stance, supported by bearish MACD, moving averages, and Bollinger Bands, along with underperformance against the Sensex.

As of 1 October 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and bearish Bollinger Bands on the weekly timeframe. The KST and OBV also indicate a mildly bearish trend on the weekly basis. The stock has underperformed significantly compared to the Sensex across multiple time frames, further reinforcing the bearish outlook.

Is Sr.Rayala.Hypo overvalued or undervalued?

As of October 14, 2025, Sr.Rayala.Hypo is considered an attractive investment due to its undervaluation compared to peers in the commodity chemicals industry, with a PE ratio of 9.98, significantly lower than competitors like Solar Industries and Gujarat Fluoroch, despite a recent stock decline of 34.32% compared to the Sensex.

As of 14 October 2025, the valuation grade for Sr.Rayala.Hypo has moved from fair to attractive, indicating a more favorable assessment of the company's stock. The company is currently considered undervalued, especially when compared to its peers in the commodity chemicals industry. Key ratios include a PE ratio of 9.98, an EV to EBITDA of 6.47, and a PEG ratio of 0.51, which suggest that the stock is trading at a significant discount relative to its earnings growth potential.<BR><BR>In comparison to peers, Sr.Rayala.Hypo's PE ratio is substantially lower than Solar Industries, which has a PE of 99.77, and Gujarat Fluoroch at 64.04, both categorized as very expensive. Additionally, Godrej Industries, another attractive peer, has a PE of 35.44, further highlighting Sr.Rayala.Hypo's relative undervaluation. Despite recent stock performance lagging behind the Sensex, particularly over the past year with a decline of 34.32% compared to a slight increase in the Sensex, the current valuation metrics suggest that Sr.Rayala.Hypo presents a compelling investment opportunity.

How has been the historical performance of Sr.Rayala.Hypo?

Sr.Rayala.Hypo has experienced declining net sales and profits from Mar'23 to Mar'25, with net sales dropping from 1,650.12 Cr to 637.82 Cr and profit after tax decreasing from 154.25 Cr to 87.47 Cr, despite some stabilization in cash flow and asset growth. Total liabilities and assets both increased during this period, indicating a challenging financial environment.

Answer:<BR>The historical performance of Sr.Rayala.Hypo shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Sr.Rayala.Hypo's net sales have seen a decline from 1,650.12 Cr in Mar'23 to 637.82 Cr in Mar'25, indicating a downward trend in revenue. The total operating income followed a similar pattern, decreasing from 1,650.12 Cr in Mar'23 to 637.82 Cr in Mar'25. The company's total expenditure also decreased from 1,472.43 Cr in Mar'23 to 545.78 Cr in Mar'25, reflecting a reduction in operational costs. Operating profit (PBDIT) has shown a decline from 211.80 Cr in Mar'23 to 131.51 Cr in Mar'25, while profit before tax increased from 190.42 Cr in Mar'23 to 119.15 Cr in Mar'25. The profit after tax also decreased from 154.25 Cr in Mar'23 to 87.47 Cr in Mar'25. On the balance sheet, total liabilities rose from 945.02 Cr in Mar'23 to 1,069.60 Cr in Mar'25, while total assets increased from 945.02 Cr to 1,069.60 Cr in the same period. Cash flow from operating activities decreased from 141.00 Cr in Mar'23 to 65.00 Cr in Mar'25, but net cash inflow improved from 12.00 Cr to 39.00 Cr. Overall, the financial performance of Sr.Rayala.Hypo reflects a challenging environment with declining revenues and profits, yet some stabilization in cash flow and asset growth.

Are Sr.Rayala.Hypo latest results good or bad?

Sree Rayalaseema Hi-Strength Hypo's latest results show a net profit increase to ₹23.29 crore and record revenue of ₹182.39 crore, but declining operating and profit margins raise concerns about profitability and operational efficiency. Overall, the results reflect a mixed performance with both positive growth and significant challenges.

The latest results for Sree Rayalaseema Hi-Strength Hypo present a mixed picture. On one hand, the company achieved a net profit of ₹23.29 crore for Q2 FY26, which is a 3.93% increase compared to the previous quarter. Additionally, revenue grew by 1.18% quarter-on-quarter and 7.14% year-on-year, reaching ₹182.39 crore, marking the highest quarterly revenue on record.<BR><BR>However, there are significant concerns regarding profitability. The operating margin has decreased to 14.78%, down 222 basis points year-on-year, indicating that rising input costs and competitive pressures are affecting the company's ability to maintain margins. The profit after tax (PAT) margin also fell by 209 basis points compared to the same quarter last year, despite a slight improvement from the previous quarter.<BR><BR>Overall, while there are positive signs in terms of revenue growth, the deterioration in margins and profitability metrics raises concerns about the company's operational efficiency and sustainability in the current market environment. Therefore, the results can be seen as a mix of good and bad, with underlying challenges that need to be addressed.

Should I buy, sell or hold Sree Rayalaseema Hi-Strength Hypo Ltd?

Why is Sree Rayalaseema Hi-Strength Hypo Ltd falling/rising?

As of 12-Apr, Sree Rayalaseema Hi-Strength Hypo Ltd's stock price is rising to 455.45, driven by strong recent performance compared to the Sensex and sector. However, declining investor participation may pose risks to sustained upward momentum.

As of 12-Apr, Sree Rayalaseema Hi-Strength Hypo Ltd's stock price is rising, currently at 455.45, with a change of 8.75 (1.96%) upward. This increase can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 7.38% compared to the Sensex's 5.77%. Additionally, the stock has shown a positive performance today, outperforming its sector by 0.77%. <BR><BR>The stock reached an intraday high of Rs 456, reflecting a 2.08% increase, which indicates strong buying interest at that level. Furthermore, the stock is currently trading above its 5-day, 20-day, and 50-day moving averages, suggesting a short-term bullish trend. However, it is important to note that there has been a decline in investor participation, with delivery volume falling by 27.8% against the 5-day average, which could indicate a potential concern for sustained upward momentum. <BR><BR>Overall, the combination of recent positive performance relative to the market and sector, along with the stock's current trading position above several moving averages, supports the observed rise in the stock price.

Which are the latest news on Sr.Rayala.Hypo?